Literature DB >> 12926190

Anticonvulsant drug hypersensitivity.

Pedro A Galindo1, Jesús Borja, Elisa Gómez, Pilar Mur, María Gudín, Rosa García, Carmen Encinas, Guillermo Romero, José A Garrido, Pilar Cortina, Francisco Feo.   

Abstract

BACKGROUND: Cutaneous adverse reactions are frequently described with anticonvulsant drugs, especially with aromatic drugs such as carbamazepine, phenytoin, and phenobarbital. Patch tests could be useful for diagnosing this clinical picture. Hypersensitivity to several anticonvulsant drugs is common but unpredictable.
MATERIAL AND METHODS: 15 patients from our allergy section, suffering from anticonvulsant skin allergy, were included. We describe their analitic alterations, responsible drugs, and anticonvulsants tolerated, the results of patch tests with anticonvulsant drugs (5% pet. and aq.), and skin biopsies wherever carried out.
RESULTS: 23 adverse skin reactions with different anticonvulsant drugs occurred in the 15 patients: 13 resulted in fever and generalized cutaneous rash, 7 patients suffered only from cutaneous rash. There was one case of palpable purpura, one of erythema multiforme (target lesions), and another one suffered only cutaneous pruritus. Eosinophilia was found in 5 cases. Liver enzymes were elevated in 9 (7 of whom suffered fever and cutaneous rash). The responsible drugs were carbamazepine (8 adverse reactions), phenytoin (5), lamotrigine (4), phenobarbital (4), sodium valproate (1), and felbamate (1). The drugs tolerated were sodium valproate (6 patients), topiramate (4), vigabatrin (2), lamotrigine (1), clonazepam (1), and gabapentin (1). We found 12 positive patch tests: 6 with carbamazepine, 3 with phenytoin and, 1 each with lamotrigine, sodium valproate and phenobarbital. Skin biopsies were carried out in 5 patients, 4 of whom showed some characteristic findings of erythema multiforme (lymphocytic exocytosis, dyskeratotic cells, vacuolation of basal cells and pigmentary incontinence) and the other one showed a typical leucocytoclastic angitis.
CONCLUSIONS: The cutaneous adverse reactions more frequently seen in our allergy section because of anticonvulsant drugs are rashes with fever. Eosinophilia and elevated levels of liver enzymes are frequently associated. This clinical picture is called "anticonvulsant hypersensitivity syndrome." The drugs implicated most frequently are carbamazepine and phenytoin. Hypersensitivity to more than one drug was variable and unpredictable. The best-tolerated drug was sodium valproate, but it was not tolerated by a patient with phenytoin and carbamazepine hypersensitivity. Patch tests are useful for diagnosing anticonvulsant hypersensitivity. The most frequently findings in the skin biopsies were typical of erythema multiforme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12926190

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  7 in total

1.  Recurrent herpes simplex virus encephalitis secondary to carbamazepine induced hypogammaglobulinaemia.

Authors:  Claire M Rice; Sarah L Johnston; David J Unsworth; Stuart C Glover; Matthew Donati; Shelley A Renowden; John Holloway; Sam D Lhatoo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

2.  Evaluation of drug patch tests in children.

Authors:  Şule Büyük Yaytokgil; Hakan Güvenir; İlknur Külhaş Celík; Özge Yilmaz Topal; Betül Karaatmaca; Ersoy Civelek; Müge Toyran; Emine Dibek Misirlioğlu
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

Review 3.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

4.  Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome.

Authors:  Cheol-Woo Kim; Gwang-Seong Choi; Chang-Ho Yun; Deok-In Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

Review 5.  Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.

Authors:  Therdpong Tempark; Shobana John; Pawinee Rerknimitr; Patompong Satapornpong; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 7.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.